JWH-161

Identifiers
IUPAC name (4aR,13bR)-2,5,5-trimethyl-8-pentyl-3,4,4a,5,8,13b-hexahydroisochromeno[3,4-b]carbazol-13-ol
CAS Number	1349418-89-8 Y
PubChemCID	10431286
ChemSpider	8606713
CompTox Dashboard(EPA)	DTXSID201029576
Chemical and physical data
Formula	C27H33NO2
Molar mass	403.566 g·mol−1
3D model (JSmol)	Interactive image
SMILES Oc3c5c1ccccc1n(c5cc2OC([C@@H]4CC/C(=C\[C@H]4c23)C)(C)C)CCCCC
InChI InChI=1S/C27H33NO2/c1-5-6-9-14-28-21-11-8-7-10-18(21)24-22(28)16-23-25(26(24)29)19-15-17(2)12-13-20(19)27(3,4)30-23/h7-8,10-11,15-16,19-20,29H,5-6,9,12-14H2,1-4H3/t19-,20-/m1/s1 Key:VDJUAFPNHZRTNL-WOJBJXKFSA-N
(verify)

JWH-161 is a cannabinoid derivative that was designed by DrJohn W. Huffman's team as a hybrid between thedibenzopyran "classical"cannabinoid drugs and the novelindole derivatives, in an attempt to unravel the differences in their binding modes to the CB₁ receptor. While retaining structural elements from both families, JWH-161 has aCB₁K_i of 19.0nM, although it was found to be slightly weaker thanTHC in animal tests.^[1]

Thiscannabinoid related article is astub. You can help Wikipedia byadding missing information.

• v
• t
• e

• Carbazoles
• Benzochromenes
• JWH cannabinoids
• Phenol ethers
• Heterocyclic compounds with 5 rings
• Nitrogen heterocycles
• Oxygen heterocycles
• Cannabinoid stubs

• Articles with short description
• Short description matches Wikidata
• Short description is different from Wikidata
• Articles without EBI source
• Chemical pages without DrugBank identifier
• Articles without KEGG source
• Articles without UNII source
• Drugs missing an ATC code
• Drugs with no legal status
• All stub articles